接受三列林治疗的具有异常性中央早熟性青春期的女孩的成年人身高
Raquel Corripio1, Leandro Soriano-Guillén2, Francisco-Javier Herrero3
1Pediatric Endocrine Department, Hospital de Sabadell, Corporació Parc Taulí, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Spain.
Frontiers in endocrinology
|December 20, 2024
概括
在患有异常性中央早熟性青春期 (CPP) 的女孩中,释放性激素类似物 (GnRHa) 治疗有助于保持遗传生长潜力. 这项研究发现,GnRHa治疗有助于实现更接近遗传潜力的身高.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 生殖医学 生殖医学
- 增长和发展 增长和发展
背景情况:
- 异常性中央早熟性青春期 (CPP) 会导致早期的桃体融合,可能会减少成年人身高.
- 激素释放激素类似物 (GnRHa) 是CPP的标准治疗方法,但它们对最终身高的影响仍有争议.
研究的目的:
- 评估GnRHa治疗对具有异常性CPP的女孩成年人身高的影响.
- 为了确定GnRHa疗法是否保留了受影响女孩的遗传生长潜力.
主要方法:
- 在西班牙,1998-2012年期间诊断出异常性CPP的女孩的前性观察研究.
- 每月服用三瑞林治疗,评估身高,骨龄和其他参数,直到达到成年人身高 (AH).
- 主要结果:AH和目标高度 (TH) 之间的差异.
主要成果:
- 分析包括358名治疗结束时和216名AH时的女孩的数据.
- 成年人身高和目标身高之间的平均差异为-1.5厘米.
- 成年人身高和预测成年人身高之间的平均差异为-2.57厘米.
结论:
- 似乎GnRHa治疗有助于保持具有特异性CPP的女孩的遗传生长潜力.
- 这些发现表明,GnRHa疗法有助于实现更接近个体遗传潜力的高度.
相关概念视频
Signs of Puberty
239
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
239
Nature and Nurture
20.4K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.4K
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K


